Less Than 50% of Accelerated Approvals Show Clinical Benefit Less Than 50% of Accelerated Approvals Show Clinical Benefit

A new study looks at 5-year outcomes of cancer drugs that were given accelerated approvals.Medscape Medical News (Source: Medscape Medical News Headlines)